Alternatives to MicRhoGAM If You Can't Fill Your Prescription

MicRhoGAM is the mini-dose formulation of Rho(D) immune globulin (RhIg) — a critical medication for Rh-negative patients following first-trimester pregnancy loss, early ectopic pregnancy, or threatened abortion at or before 12 weeks gestation. Since the RhIg shortage that began in late 2023, MicRhoGAM has been difficult to find at retail pharmacies across the United States.

The good news: you have real, FDA-approved options. This guide covers the alternatives your provider can prescribe if MicRhoGAM is unavailable.

Why Are Alternatives Even Possible?

All Rho(D) immune globulin products share the same active ingredient and mechanism of action: they deliver concentrated IgG anti-D antibodies that prevent a Rh-negative person's immune system from becoming sensitized to Rh-positive blood cells. The brand name is less important than the dose and timing. As the American College of Obstetricians and Gynecologists (ACOG) noted in its RhIg shortage Practice Advisory, if a preferred brand is not available, an equivalent product may be substituted.

Alternative 1: HyperRHO S/D Mini-Dose (Grifols) — Direct Equivalent

HyperRHO S/D Mini-Dose, manufactured by Grifols Therapeutics LLC, is the direct mini-dose equivalent to MicRhoGAM. It contains 50 mcg (250 IU) of Rho(D) immune globulin — identical in dose — and is indicated for the same first-trimester obstetric situations. If your prescription says "MicRhoGAM" and it's unavailable, ask your pharmacist whether HyperRHO S/D Mini-Dose is in stock. In most cases, your provider can write a brand-flexible prescription that allows this substitution.

Alternative 2: Full-Dose Rho(D) Immune Globulin Products

Per the prescribing information for MicRhoGAM, a full-dose preparation may be used if the mini-dose is not available. Full-dose products contain 300 mcg (1500 IU) — six times the mini-dose — but clinical evidence supports their use in first-trimester situations when the mini-dose is unavailable. Your provider will guide this decision.

Full-dose RhIg products currently available in the U.S.:

RhoGAM Ultra-Filtered PLUS (Kedrion Biopharma): 300 mcg (1500 IU) IM; same manufacturer as MicRhoGAM; the full-dose sibling formulation.

HyperRHO S/D Full Dose (Grifols Therapeutics): 300 mcg (1500 IU) IM; widely available; indicated for postpartum prophylaxis and other obstetric uses.

Rhophylac (CSL Behring AG): 300 mcg (1500 IU); can be given IM or IV; useful alternative with a different manufacturer's supply chain.

WinRho SDF (Kamada Ltd.): Available in multiple strengths IM or IV; shortage was resolved August 2024; may also be used for ITP in addition to obstetric indications.

Which Alternative Is Right for Me?

Your provider will decide which product to use based on what's available and your clinical situation. Generally:

For first-trimester events (12 weeks or less): HyperRHO S/D Mini-Dose is the first choice alternate; full-dose products are acceptable when mini-dose is unavailable.

For later-pregnancy events (after 12 weeks): Full-dose products (RhoGAM 300 mcg) are standard; MicRhoGAM is NOT appropriate for these situations regardless of availability.

What About Non-Invasive Prenatal Testing (NIPT) Instead?

In response to the RhIg shortage, ACOG and researchers have increasingly supported using cell-free DNA non-invasive prenatal testing (NIPT) to determine fetal Rh(D) status. If the fetus is confirmed Rh-negative, the Rh-negative mother does not need RhIg at all — potentially conserving doses for those who truly need them. BillionToOne's UNITY Fetal Antigen NIPT test demonstrated 100% accuracy for fetal RhD detection in a 2025 peer-reviewed study.

However, NIPT for fetal Rh typing is most useful in ongoing pregnancies, not typically for a completed first-trimester pregnancy loss. Discuss with your provider whether this testing is relevant to your situation.

What If No RhIg Is Available at All?

If no Rho(D) immune globulin product is available in your area, contact your provider immediately. In rare cases of true unavailability, hospitals with institutional supply or regional blood banks may have stock. Your provider should document the shortage and its impact on your care.

To find MicRhoGAM or an alternative in stock near you, medfinder calls pharmacies in your area and texts you the results. See also: How to find MicRhoGAM in stock near you.